View in EDS HTML Full Text PDF Full Text

Corporate Strategies to Market PAX Vaporizers for Cannabis Use Under Federal Restrictions in the United States.

Saved in:
Bibliographic Details
Title: Corporate Strategies to Market PAX Vaporizers for Cannabis Use Under Federal Restrictions in the United States.
Authors: Timberlake, David S. (AUTHOR), Paredes, Jacob (AUTHOR), Rhee, Joshua (AUTHOR), Sandhu, Ashish (AUTHOR), Phan, Yvonne (AUTHOR), Martinez-Santos, Alejandro (AUTHOR), Pechmann, Cornelia (AUTHOR)
Source: Substance Use & Misuse. 2026, Vol. 61 Issue 5, p733-740. 8p.
Subjects: Federal government, Medical marijuana, Archives, Documentation, Research funding, Statistical sampling, Content analysis, Marketing, Industries, Nebulizers & vaporizers, Cannabis (Genus), Drug laws, Government regulation, Therapeutics
Geographic Terms: United States
Abstract: Objective: Legal restrictions have limited the overt marketing of cannabis and associated paraphernalia in the United States. This study assessed how one company, PAX Labs, marketed its devices for vaporizing cannabis while abiding by U.S. federal law on drug paraphernalia. Methods: Internal documents from PAX Labs, dated January 2014 through December 2018, were accessed via the JUUL Labs Collection at University of California, San Francisco. An initial Boolean query of the collection followed by snowball sampling yielded 421 informative documents for a content analysis. Two additional sources, archived PAX webpages and political/lobbying expenditure reports, were analyzed to triangulate findings on messaging and legislative support, respectively. Results: The company first marketed PAX devices for vaporizing tobacco, transitioned to marketing use for an unnamed plant material, and then promoted cannabis vaporization as U.S. state cannabis laws became more liberalized. PAX Labs carefully navigated marketing restrictions on drug paraphernalia through use of ambiguous messaging (i.e., "plant agnostic") and recruitment of cannabis-related third-party affiliates as a means of distancing the company from cannabis promotion. Although PAX Labs did not publicly or financially support U.S. state cannabis ballot measures in 2016, the company proposed to sponsor events facilitating public conversations on cannabis legalization. Conclusion: Strategies used by PAX Labs pose challenges for government agencies that do not have purview to regulate cannabis vaporizers that are vaguely marketed. Yet, government agencies can better assess adherence to federal law on drug paraphernalia by carefully monitoring vaporizer companies' use of ambiguous messaging, affiliate marketing, and cannabis forum sponsorship. [ABSTRACT FROM AUTHOR]
Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 192503382
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Corporate Strategies to Market PAX Vaporizers for Cannabis Use Under Federal Restrictions in the United States.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Timberlake%2C+David+S%2E%22">Timberlake, David S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paredes%2C+Jacob%22">Paredes, Jacob</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rhee%2C+Joshua%22">Rhee, Joshua</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sandhu%2C+Ashish%22">Sandhu, Ashish</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Phan%2C+Yvonne%22">Phan, Yvonne</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martinez-Santos%2C+Alejandro%22">Martinez-Santos, Alejandro</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pechmann%2C+Cornelia%22">Pechmann, Cornelia</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Substance+Use+%26+Misuse%22">Substance Use & Misuse</searchLink>. 2026, Vol. 61 Issue 5, p733-740. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Federal+government%22">Federal government</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+marijuana%22">Medical marijuana</searchLink><br /><searchLink fieldCode="DE" term="%22Archives%22">Archives</searchLink><br /><searchLink fieldCode="DE" term="%22Documentation%22">Documentation</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Statistical+sampling%22">Statistical sampling</searchLink><br /><searchLink fieldCode="DE" term="%22Content+analysis%22">Content analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Marketing%22">Marketing</searchLink><br /><searchLink fieldCode="DE" term="%22Industries%22">Industries</searchLink><br /><searchLink fieldCode="DE" term="%22Nebulizers+%26+vaporizers%22">Nebulizers & vaporizers</searchLink><br /><searchLink fieldCode="DE" term="%22Cannabis+%28Genus%29%22">Cannabis (Genus)</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+laws%22">Drug laws</searchLink><br /><searchLink fieldCode="DE" term="%22Government+regulation%22">Government regulation</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22United+States%22">United States</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective: Legal restrictions have limited the overt marketing of cannabis and associated paraphernalia in the United States. This study assessed how one company, PAX Labs, marketed its devices for vaporizing cannabis while abiding by U.S. federal law on drug paraphernalia. Methods: Internal documents from PAX Labs, dated January 2014 through December 2018, were accessed via the JUUL Labs Collection at University of California, San Francisco. An initial Boolean query of the collection followed by snowball sampling yielded 421 informative documents for a content analysis. Two additional sources, archived PAX webpages and political/lobbying expenditure reports, were analyzed to triangulate findings on messaging and legislative support, respectively. Results: The company first marketed PAX devices for vaporizing tobacco, transitioned to marketing use for an unnamed plant material, and then promoted cannabis vaporization as U.S. state cannabis laws became more liberalized. PAX Labs carefully navigated marketing restrictions on drug paraphernalia through use of ambiguous messaging (i.e., "plant agnostic") and recruitment of cannabis-related third-party affiliates as a means of distancing the company from cannabis promotion. Although PAX Labs did not publicly or financially support U.S. state cannabis ballot measures in 2016, the company proposed to sponsor events facilitating public conversations on cannabis legalization. Conclusion: Strategies used by PAX Labs pose challenges for government agencies that do not have purview to regulate cannabis vaporizers that are vaguely marketed. Yet, government agencies can better assess adherence to federal law on drug paraphernalia by carefully monitoring vaporizer companies' use of ambiguous messaging, affiliate marketing, and cannabis forum sponsorship. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=192503382
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10826084.2025.2575919
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 733
    Subjects:
      – SubjectFull: Federal government
        Type: general
      – SubjectFull: Medical marijuana
        Type: general
      – SubjectFull: Archives
        Type: general
      – SubjectFull: Documentation
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Statistical sampling
        Type: general
      – SubjectFull: Content analysis
        Type: general
      – SubjectFull: Marketing
        Type: general
      – SubjectFull: Industries
        Type: general
      – SubjectFull: Nebulizers & vaporizers
        Type: general
      – SubjectFull: Cannabis (Genus)
        Type: general
      – SubjectFull: Drug laws
        Type: general
      – SubjectFull: Government regulation
        Type: general
      – SubjectFull: Therapeutics
        Type: general
      – SubjectFull: United States
        Type: general
    Titles:
      – TitleFull: Corporate Strategies to Market PAX Vaporizers for Cannabis Use Under Federal Restrictions in the United States.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Timberlake, David S.
      – PersonEntity:
          Name:
            NameFull: Paredes, Jacob
      – PersonEntity:
          Name:
            NameFull: Rhee, Joshua
      – PersonEntity:
          Name:
            NameFull: Sandhu, Ashish
      – PersonEntity:
          Name:
            NameFull: Phan, Yvonne
      – PersonEntity:
          Name:
            NameFull: Martinez-Santos, Alejandro
      – PersonEntity:
          Name:
            NameFull: Pechmann, Cornelia
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 10826084
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Substance Use & Misuse
              Type: main
ResultId 1